Insiders Back Cebix With $30.9M, As New CEO Prepares For Phase II Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
The La Jolla, Calif.-based start-up will soon begin a mid-stage trial on Ersatta, a long-acting drug to treat diabetic complications.